Close

Positive Trend for MEI Pharma's (MEIP) Pracinostat in Frontline AML Continues; Roth Affirms at 'Neutral' Jun 12, 2015 11:21AM
Notable Analyst Rating Changes 3/23: (SPLS) (ELY) (NMM) Upgraded; (NVDA) (CCL) (SHW) Downgraded Mar 23, 2015 10:45AM
UPDATE: Roth Capital Downgrades MEI Pharma (MEIP) to Neutral; Future of Pracinostat Now in Question Mar 23, 2015 10:20AM
Notable Analyst Rating Changes 2/20: (MRVL) (DSW) (KN) Upgraded; (FUEL) (HLSS) (REGN) Downgraded Feb 20, 2015 10:46AM
Notable Analyst Rating Changes 2/6: (IMGN) (FBP) (WWE) Upgraded; (YELP) (P) (VIAB) Downgraded Feb 6, 2015 10:39AM


Dec 17, 2014 05:00PM MEI Pharma (MEIP) Completes 10M Common Offering
Dec 12, 2014 08:40AM MEI Pharma (MEIP) Prices 10M Share Offering at $4/Share
Oct 16, 2014 07:53AM Roth Capital Adds MEI Pharma (MEIP) to Focus List; Multiple Key Inflection Points Coming
Jun 10, 2014 10:41AM Roth Affirms 'Buy' Rating on MEI Pharma (MEIP); New AML Treatment Data Bolsters Confidence
May 5, 2014 02:54PM Roth Positive on MEI Pharma (MEIP) Following ME-344 Phase 1b Initiation
Apr 7, 2014 11:57AM Streetinsider.com's Hot Lunchtime Reads 04/07: (KR) (MSFT) (SRPT) (MDVN)
Apr 7, 2014 11:14AM Pre-Clinical Data for MEI Pharma's (MEIP) Pracinostat Will Set Development Tone - Roth Capital
Oct 25, 2013 08:46AM MEI Pharma (MEIP) Prices 4.38M Common Offering at $8/Share